Sunil Nadar, Senior Consultant Cardiologist, Sultan Qaboos University Hospital, Muscat, Oman,Gregory Lip, Price-Evans Chair of Cardiovascular Medicine, University of Liverpool, Liverpool, UK

Sunil K Nadar is a Consultant Cardiologist at Sultan Qaboos University Hospital in Muscat, Oman. Prior to this he worked as a Consultant Cardiologist at the NHS in Birmingham, UK. He did his research MD on platelet activation in hypertension and completed his specialist cardiology training in the West Midlands, UK. Dr Nadar is a Co-Editor with the Journal of Human Hypertension and an Associate Editor with the Sultan Qaboos University Medical Journal. He is currently involved in research work investigating the effects of thalassemia on the heart, the psychological impact of admission on patients with heart disease, and community awareness of the dangers of high dietary salt intake. He is also the coordinator for the May Measurement Month programme in Oman.

Gregory Y.H. Lip, is Price-Evans Chair of Cardiovascular Medicine at the University of Liverpool and Director of the Liverpool Centre for Cardiovascular Science at the University of Liverpool and Liverpool Heart & Chest Hospital, UK. He is also Distinguished Professor at Aalborg University, Denmark, and Adjunct Professor at Seoul National University and Yonsei University, Seoul, Korea. In 2014 Professor Lip was ranked by Expertscape as the world's leading expert in the understanding and treatment of Atrial Fibrillation. He was on the writing committee for various international guidelines and has acted at a senior editorial level for major international textbooks and journals. Professor Lip's current research interests range from epidemiology to pathophysiology, translational research, clinical risk assessment and trajectories of risk, patient management pathways, and applied health research.

Part 1: Epidemiology, pathogenesis and diagnosis
1. Epidemiology of hypertension, Sunil K. Nadar and Stephanie Harrison
2. Pathophysiology of hypertension, Sheon Mary, Giacomo Rossitto, and Christian Delles
3. Secondary hypertension, Gurbhej Singh and Gurpreet Wander
4. Diagnosis and investigation of hypertension, Martin Wolley and Michael Stowasser
Part 2: Complications of hypertension
5. Hypertension: a cardiovascular risk factor, Thomas Salmon, James Hatherley, and Rajiv Shankaranarayan
6. Left ventricular hypertrophy, Yuichiro Yano and Sunil K. Nadar
7. Atrial fibrillation and hypertension, Mohammed Najeeb Al-Rawahi
8. The brain in Hypertension, Arun R. Gujjar
9. The kidneys in hypertension, Sarah Ahmad and Jordana B. Cohen
10. The eye in hypertension, Peck Lin Lip
Part 3: Management of hypertension
11. Overview of the guidelines on the management of hypertension, Gregory Y.H. Lip and Sunil K. Nadar
12. Hypertension and cardiovascular risk management, James P. Sheppard and Sunil K. Nadar
13. Non-pharmacological management of hypertension, Benjamin J.R. Buckley and Stephanie J. Finnie
14. Diuretics in hypertension, Harsh Goel and Ashish Kumar
15. Beta blockers in hypertension, Hatim Al Lawati
16. Calcium channel blockers and hypertension, Stephanie Lip and Sandosh Padmanabhan
17. Blockers of the Renin- Angiotensin- Aldosterone system in hypertension, Ify R. Mordi and Chim C. Lang
18. Other antihypertensive agents, Shankar Patil, Muzahir Tayebjee, and Sunil K. Nadar
19. Renal denervation, Vikas Kapil
20. Improving medication adherence in hypertension, Hassan Al-Riyami and Dierdre A. Lane
Part 4: Special conditions
21. Hypertension in pregnancy: Physiopathological, preventive, therapeutic and long-term considerations, Gloria Valdés
22. Hypertensive emergencies, Alena Shantsila
23. Treatment of the older adult, Asangaedem Akpan
24. Diagnosis and management of resistant hypertension, Fang-Fei Wei, Chen Liu, and Jan A. Staessen
25. Hypertension in patients with diabetes mellitus, Daniel J. Cuthbertson